NDC 43353-282 – Oxybutynin Chloride Extended Release
Oxybutynin Chloride 5 mg/1 · Tablet, Extended Release · Oral
Product NDC43353-282
Product details
- Brand name
- Oxybutynin Chloride Extended Release
- Generic name
- Oxybutynin Chloride
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA078503
- Marketed since
- March 9, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cholinergic Muscarinic Antagonist
Active ingredients
- Oxybutynin Chloride 5 mg/1
Uses, dosage, side effects and warnings for Oxybutynin Chloride →
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 43353-282-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-282-30) | Mar 2, 2017 |
| 43353-282-53 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-282-53) | Mar 2, 2017 |
| 43353-282-60 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-282-60) | Mar 2, 2017 |
| 43353-282-80 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-282-80) | May 31, 2023 |
Other Oxybutynin Chloride products
- 50090-6199 Oxybutynin Chloride 5 mg/1 · Tablet · A-S Medication Solutions
- 50090-6966 Oxybutynin Chloride 5 mg/1 · Tablet · A-S Medication Solutions
- 50090-4307 Oxybutynin Chloride 10 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-4622 Oxybutynin Chloride 5 mg/1 · Tablet · A-S Medication Solutions
- 50090-6638 Oxybutynin Chloride 5 mg/1 · Tablet · A-S Medication Solutions
- 50090-8078 Oxybutynin Chloride 5 mg/1 · Tablet · A-S Medication Solutions
- 50090-5822 Oxybutynin Chloride 5 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-6673 Oxybutynin Chloride 10 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-6840 Oxybutynin Chloride 5 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-7766 Oxybutynin Chloride 5 mg/1 · Tablet · A-S Medication Solutions
- 50090-6967 Oxybutynin Chloride 5 mg/1 · Tablet · A-S Medication Solutions
- 16729-318 Oxybutynin Chloride 10 mg/1 · Tablet, Extended Release · Accord Healthcare, Inc.